
RDY News
Dr. Reddy's Laboratories Limited
$14.73
-$0.11(-0.74%)
69
Overall
85
Value
75
Tech
47
Quality
Market Cap
$12.39B
Volume
1.56M
52W Range
$11.36 - $15.67
Target Price
$14.53
RDY news: the latest Dr. Reddy's Laboratories Limited headlines, press releases and market updates, newest first.
Latest RDY News
- ARD Grup Repurchases 4,000 ARDYZ SharesTipRanks Turkey Auto-Generated Newsdesk · Nov 13, 2026
- ARD Grup Reports 21,500 ARDYZ Share RepurchaseTipRanks Turkey Auto-Generated Newsdesk · Nov 12, 2026
- ARD Grup Bilisim Consolidated Assets Total TL11,626,141,954 at Sept. 30TipRanks Turkey Auto-Generated Newsdesk · Nov 9, 2026
- ARD Grup Reports Consolidated Operating Review for January–September 2026TipRanks Turkey Auto-Generated Newsdesk · Nov 9, 2026
- ARD Grup Wins $4.53 Million Defense AI Infrastructure OrderTipRanks Turkey Auto-Generated Newsdesk · Nov 9, 2026
- ARD Grup Reaches 261,304 Shares in Buy-Back ProgramTipRanks Turkey Auto-Generated Newsdesk · Nov 6, 2026
- ARD Grup Completes Further ARDYZ Share BuybackTipRanks Turkey Auto-Generated Newsdesk · Nov 4, 2026
- ARD Grup Reports Latest ARDYZ Share BuybackTipRanks Turkey Auto-Generated Newsdesk · Nov 3, 2026
- ARD Grup’s Buybacks Reach 245,000 SharesTipRanks Turkey Auto-Generated Newsdesk · Nov 2, 2026
- Borsa Istanbul Activates Circuit Breaker in ARDYZ TradingTipRanks Turkey Auto-Generated Newsdesk · Oct 30, 2026
- ARD Grup Bilisim Ramps Up Share Buybacks on Borsa IstanbulTipRanks Turkey Auto-Generated Newsdesk · Oct 30, 2026
- Dr. Reddy’s Files SEC Form 6-K and Publishes Q2 FY27 Earnings Call TranscriptTipRanks Auto-Generated Newsdesk · Oct 29, 2026
- Dr. Reddy’s Gets Favorable USFDA VAI Status at Srikakulam PlantTipRanks Auto-Generated Newsdesk · Oct 29, 2026
- ARD Grup Bilisim Steps Up Share Buy-Backs on Borsa IstanbulTipRanks Turkey Auto-Generated Newsdesk · Oct 28, 2026
- ARD Grup Bilisim Wins NVIDIA-Based AI Infrastructure Order for UK End UserTipRanks Turkey Auto-Generated Newsdesk · Oct 28, 2026
- Dr. Reddy’s Files Unmodified Auditor Review on September 2026 Interim ResultsTipRanks Auto-Generated Newsdesk · Oct 26, 2026
- Dr. Reddy’s Laboratories Files Q2 FY 2027 Unaudited Results with SEC and Indian ExchangesTipRanks Auto-Generated Newsdesk · Oct 23, 2026
- Dr. Reddy’s Elevates Aurigene CEO Akhil Ravi to Head API and ServicesTipRanks Auto-Generated Newsdesk · Oct 23, 2026
- Dr. Reddy’s Releases Q2 FY27 Unaudited Results PresentationTipRanks Auto-Generated Newsdesk · Oct 23, 2026
- Dr. Reddy’s Interim Q2 FY 2026 Results Receive Clean Auditor ReviewTipRanks Auto-Generated Newsdesk · Oct 23, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RDY | $14.73 | -0.7% | 1.56M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Dr. Reddy's Laboratories Limited Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW